ABSTRACT. The IGF-I gene from leukocyte DNA of a control population of normal stature was studied using Southern blotting. Restriction fragment lengths for 21 enzymes were determined and three restriction fragment length polymorphisms (RFLP) were found (EcoRV, HindIII, and PvuII). In addition, the IGF-I gene of 64 constitutionally short subjects, five Pygmies, and 10 constitutionally tall subjects was analyzed. No IGF-I gene alterations were detectable by Southern blot in any of these conditions. Linkage analysis using genetic markers (RFLP) yielded results that were uninformative for five constitutionally short families investigated, owing to the limited number of RFLP and their low incidence (17% for the 5.2-kb HindIII, 5-kb PvuII RFLP alleles, and 13% for the 13-kb EcoRV RFLP allele). The EcoRV RFLP was found to map near Exon 1. The incidence of the 13-kb polymorphic allele with EcoRV proved to be lower (4%) in the group with constitutionally short stature than in controls. These results could suggest that modifications in the region of the IGF-I gene may be involved in constitutionally short subjects. (Pediatr Res 27:488-491, 1990) Abbreviations constitutionally variant stature were selected on the basis of criteria defined previously (3, 4). Sixty-four short subjects were studied (55 of whom were unrelated). Fifty-eight were children and adolescents, and six were fully grown. Ht was below -2 SD for the French population (7), the average being -2.7 SD. Birth size was 49 cm a 1.2 (mean a SD). The mean body mass index (wt/ht2) was 15.8 k 1.6, which is within the normal range. Five families were also investigated, comprising 24 subjects of whom 13 were constitutionally short. All short subjects had GH levels exceeding 14 ng/mL after ornithine infusion and the mean of the GH peaks (22.7 k 7.3 ng/mL, mean + SD) was no different from that of normals (8). Ten constitutionally tall subjects (nine children and adolescents and one adult) were studied (ht above +2 SD, the mean being +3.4 SD). In all cases, wt was within the normal range (mean f I SD for ht). Thyroid hormone levels were normal in all subjects (free T4: 14.2 + 2.9 pg/mL, TSH:
(wt/ht2) was 15.8 k 1.6, which is within the normal range. Five families were also investigated, comprising 24 subjects of whom 13 were constitutionally short. All short subjects had GH levels exceeding 14 ng/mL after ornithine infusion and the mean of the GH peaks (22.7 k 7.3 ng/mL, mean + SD) was no different from that of normals (8) . Ten constitutionally tall subjects (nine children and adolescents and one adult) were studied (ht above +2 SD, the mean being +3.4 SD). In all cases, wt was within the normal range (mean f I SD for ht). Thyroid hormone levels were normal in all subjects (free T4: 14.2 + 2.9 pg/mL, TSH:
1.38 f 0.5 pU/mL). Serum IGF levels were determined after separation by acidic gel filtration using methods reported earlier (9) . IGF-I was measured by RIA and IGF-I1 by protein-binding assay using a cerebrospinal fluid binding protein with a selective afinity for IGF-I1 (10) .
IGF-I levels were within the normal range (mean f 2 SD) in the 58 constitutionallv short children and adolescents. but two-GH, growth hormone thirds of them (37 of <8) had values below the normal'age mean RFLP, restriction fragment length polymorphism (Fig. I) . Although there was no statistically significant difference between this group and controls, an earlier study covering a much larger number of subjects did reveal significantly lower levels (4). The mean value for the six fullv-grown subiects was The well-established role of IGF-I in postnatal growth is reflected clinically by variations in serum levels that are related to GH status in particular (I). Pygmies, who have normal GH secretion, exhibit a primary IGF-I deficiency (2) . In children and adolescents with constitutionally variant stature, short subjects on average have lower, and tall subjects have higher levels of IGF-I than normals (3) (4) (5) (6) . Although these statural deviations represent etiologically heterogenous groups, the frequently familial nature of the deviations suggests that genetic alterations may be involved. We therefore set out to analyze the IGF-I gene using different restriction endonucleases, first in a control population, then in subjects with constitutionally variant stature and in Pygmies.
378 +'79 ng/mL (mean ? SD), which ; s iimilar to-that for normal adults (300 k 56 ng/mL). The constitutionally tall adult in this study had a normal IGF-I level (326 ng/mL). All but two of the tall children and adolescents, however, had IGF-I levels above the normal age mean (Fig. I) . Here, too, an earlier study on larger numbers of subjects had shown significantly higher IGF-I levels in constitutionally tall subjects than in controls (3, 6) . IGF-I1 levels were normal in all subjects with constitutionally variant stature.
Samples were obtained from five adult Pygmies (four men and one woman) of the Aka tribe (Lobaye, Central African Republic). The mean ht of the men in the tribe was 154.2 f 6.3 cm (mean + SD) and of the women, 144.2 + 6.4 cm (1 1). These ht are below -3 SD of the normal French population.
MATERIALS AND METHODS
Preparation of genomic DNA. The procedure used was that of Miller et a/. (12) with minor modifications. Leukocyte DNA was Control subjects for gene analysis were French adults ( n = 56) isolated from 10-20 mL blood (or buffy coats of nucleated cells) of r~ormal stature (normal range * 1 SD) (7) . Subjects with collected in anticoagulant (EDTA). Blood samples were stored The lengths of the fragments were determined by Southern blot analysis with 21 enzymes, three of which yield polymorphism (*RFLP). i The difference in incidence of the 13-kb allele between constitutionally short subjects and controls was significant ( p < 0.02) ( x 2 test).
DNA probes. The human liver IGF IA cDNA insert (1073 bp) from phage A-TG03 (13) was subcloned in plasmid PGEM4 (pTG 3906). The 660-bp EcoRI-BamHI fragment, which contains the 5'-untranslated region, the coding region, and part o f the 3'-untranslated region corresponding to the IGF IA m R N A (Exons 1 , 2, 3, and 5 ) was used, as was the 152-bp 5'-EcoRI-
RsaI fragment of the IGF-I cDNA (which maps to Exon 1) was used as probe, only the 1 1.5-and 13-kb polymorphic fragments were observed with the EcoRV-digested DNA (Fig. 3b) .
Human IGF DNA in Subjects with Growth Abnormalities. Constitutionally short subjects. The patterns obtained from Southern blotting using various enzymes, AvaII, BamHI, BglI, BglII, EcoRV, HindIII, Hinfl, PvuII, and TaqI, were identical to those in controls. Neither IGF-I gene deletions nor abnormalities in the genomes of these subjects were detectable by the method used. EcoRV and HindIII were used as genetic markers to investigate the incidence of RFLP in this group (55 unrelated individuals). The incidence of RFLP for HindIII was similar to that in the control population. That of the polymorphic 13-kb EcoRV was, however, significantly lower (as evaluated by x2 test, p < 0.02) ( Table 2 ). Analysis of five families using HindIII and EcoRV was uninformative for the IGF-I gene.
Constitutionally tall subjects. The IGF-I gene of 10 such subjects was analyzed using the enzymes HaeIII, BglI, EcoRV, NindIII, PvuII, and TaqI, and no abnormalities were detected in the patterns of the blots.
Pygmies. Five Pygmy samples were analyzed using EcoRV, HindIII, PvuII, and TaqI, yielding results identical to those of controls (Fig. 4) .
DISCUSSION
Analysis of the IGF-I gene in a control population of normal ht enabled us to characterize the restriction profiles and determine fragment lengths for 21 restriction enzymes, as well as to detect RFLP. Of the enzymes tested, only three (EcoRV, HindIII, and PvuII) revealed polymorphism (1 5-18), indicating that there is high conservation of the IGF-I gene. HindIII and PvuII RFLP were found to be linked. Variation of restriction fragment length between the two alleles was 300 bp for the two enzymes, which suggests that an insertion-deletion mechanism would account for the variation (1 9). The incidence of HindIII and PvuII polymorphism in the French population studied was 17% for one allele and 83% for the other. Allele polymorphisms for EcoRV were 13 and 87%. The RFLP with EcoRV and HindIII were not linked. Site polymorphisms for HindIII and PvuII mapped to the region around Exon 5 (18) , whereas that for EcoRV was found to map around Exon 1.
With these results for the IGF-I gene in a normal population, it was possible to make comparisons with those for subjects with constitutionally variant stature. In short subjects where the etiology of the condition is probably heterogeneous, differences in IGF-I levels may well reflect differences in G H secretion not detected by pharmacological tests (20) (21) (22) . However, Zadik et al. (22) , studying 24-h integrated GH concentrations, found more than half of the values within the normal range. A possible hypothesis would therefore be that individual variations exist in the expression of the IGF-I gene which accompany normal levels of G H (6) . In our studies, Southern blotting revealed no significant deletions or other anomalies in the IGF-I gene of any of these subjects, even in short children with markedly reduced IGF-I levels. The short stature of Pygmies has been attributed to a primary IGF-I deficiency (2), although a recent report suggests a possible defect at the GH receptor (23) . In our study, the restriction profile obtained with leukocyte DNA indicated no detectable anomaly of the IGF-I gene.
With a view to determining whether finer modifications of the IGF-I gene structure may be responsible for the variations in the levels of this factor, we used the RFLP as genetic markers to trace transmission of the different alleles of the IGF-I gene within families. The limited number of RFLP, i.e. three, of which two were linked, and their low incidence (17 and 13%) gave insufi-cient information for linkage analysis of the five families tested. Nonetheless, the proportion of the 13-kb polymorphic allele obtained with EcoRV proved to be lower (4%) in the 5 5 unrelated constitutionally short subjects than in controls (13%). This means that constitutionally short individuals may comprise a group that is genetically different from normals. More refined techniques (such as genome amplification by the polymerase chain reaction) will need to be applied to establish whether or not anomalies of the IGF-I gene exist in these subjects.
